Atlas Trials

Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis

Clinical trial NCT00432861 · COMPLETED

Trial details

NCT number
NCT00432861
Sponsor
Digestive Care, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cystic FibrosisPancreatic Insufficiency
Start date
2007-01-01
Primary completion
2007-09-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.